Selling Tickets Sample Clauses

Selling Tickets. Taking tickets
Sample 1Sample 2Sample 3See All (8)
AutoNDA by SimpleDocs
Selling Tickets. 13.1 We will conduct the exclusive sale, distribution and issue of all tickets for your Event(s) ticket sales (Ticket Sales) through Adelaide Fringe’s ticketing system ‘FringeTIX’: 13.1.1 for ticket categories and prices as inputted by either Adelaide Fringe, or you into the AVR site; 13.1.2 for selected customers associated with Adelaide Fringe sponsors as part of an exclusive pre-sale, from 17 December 2020; 13.1.3 for all customers from 18 December until 21 March 2021; and 13.1.4 for complimentary tickets (including but not limited to media representatives and Honey Pot participants accredited by us) as authorised by you. 13.2 Provided all requirements are met, Adelaide Fringe may release tickets earlier than the above dates, this will occur only with prior written consultation between you and Adelaide Fringe 13.3 Adelaide Fringe has exclusive ticketing sales rights to all 2021 Adelaide Fringe Events and this is a condition of your registration and participation, unless you receive prior approval in writing by the Adelaide Fringe Director & Chief Executive. 13.4 You may announce your Adelaide Fringe season prior to the on sale date of 18 December 2020 but you are not permitted to sell tickets before this date. 13.5 If you have a split allocation agreement with Adelaide Fringe, you must not sell tickets to your event prior to the official Adelaide Fringe program on sale date, unless you have agreed an early on sale date in writing with Adelaide Fringe. 13.6 Adelaide Fringe’s ticketing operations are carried out observing the LPA Guidelines. In line with the LPA Guidelines, Adelaide Fringe reserves the right to exchange or refund a ticket at management’s discretion. Adelaide Fringe will not sell tickets to an Event without a fixed address (unless for a Digital Event). 13.7 Adelaide Fringe will not offer refunds, unless the refund meets the requirements stated in the LPA Guidelines. 13.8 Adelaide Fringe will offer exchanges to customers who fit within the below criteria. An $8.50 administration exchange fee will be charged to the customer, per exchange transaction. This fee is kept by Adelaide Fringe. Exchanges will be performed at the discretion of Adelaide Fringe in line with the criteria below. Adelaide Fringe will not seek permission from the artist or presenter unless it falls outside of this criteria. 13.8.1 An exchange will be approved if: (a) The original performance is not sold out; and (b) The customer has provided proof of the destruction of the...
Sample 1Sample 2See All (5)
Selling Tickets. At present, Sellers may only list and sell Tickets to CFC home Premier League matches. Box CFC Season Ticket Holders may only list and sell the Tickets for an entire box at an event, and not individual Tickets. To sell Tickets, a Seller lists the Tickets in the CFC database via the Site. The Seller's Ticket information will be pre-loaded, including the seat location and price. The Seller has to provide information such as the match, sale end date and any applicable Ticket splitting, all in accordance with the process outlined in the help pages of the Site. As a Seller, You also grant to CFC a nonexclusive, transferable, worldwide, paid-up, royalty-free right and license to reproduce, modify, adapt, publish and display on the Site Your descriptions of Tickets listed for sale. This is so we can promote the sale of Tickets and items that You list for sale. Tickets remain the property of CFC at all times.
Sample 1Sample 2
Selling Tickets. At present, Sellers may only list and sell tickets to CFC home Premier League matches. Box season ticket holders may only list and sell the tickets for an entire box at an event, and not individual tickets. To sell tickets, a Seller lists the tickets in the CFC database via the Site. The Seller's season ticket information will be pre-loaded, including the seat location and price. The Seller has to provide information such as the match, sale end date and any applicable ticket splitting, all in accordance with the process outlined in the help pages of the Site. As a Seller, You also grant to CFC a non-exclusive, transferable, worldwide, paid-up, royalty-free right and license to reproduce, modify, adapt, publish and display on the Site your descriptions of tickets listed for sale. This is so we can promote the sale of tickets and items that You list for sale.
Sample 1
Selling Tickets. A. Renter is responsible for selling tickets for the event. Before tickets can go on sale, Xxxxx Center must approve renter’s ticketing plan, ticket sample* and renter must provide City of Seattle Admission Tax documentation (see B, C & D of this section and Exhibit 3 for more information.) *All tickets must show presenter, event name, event date and time, theater name and address, established price, service charge and admissions tax if applicable, and total price on both ends of a perforated ticket. General Admission tickets if priced by section must be color coded or the section row numbers must be printed on ticket. Reserved tickets must also show the door letter, row letter and seat number on both ends of ticket. B. Ticket sales may be subject to the City of Seattle admissions tax. For more information, go to Admission Tax - License and Tax Administration | xxxxxxx.xxx on the City of Seattle website. C. Renter must provide Xxxxx Center with either a copy of its Certificate of Registration for Admission Tax issued by the city or a Certificate of Exemption as proof that it is exempt from having to obtain such a registration. This documentation must be provided prior to tickets going on sale. D. Renter is solely responsible for the collection and remittance of admission taxes. Xxxxxx agrees to fully indemnify the University of Washington for any and all expenses Xxxxx Center might incur in connection with an assessment of Admission Taxes by the City of Seattle, including but not limited to reimbursement to the University if it remits the taxes, the fair market value of time spent by the University or its legal counsel in responding to an inquiry by the City of Seattle as to whether the proper amount of Admissions Tax was remitted for Renter’s event, and any legal costs associated with such an inquiry. E. Renter may not print, sell or give away more tickets than the capacity of Xxxxx’x mainstage Xxxxxxxx Xxxxxx Xxxxxxx Theater, which is 1201, plus 4 wheelchair spaces. “Standing room” and sitting on aisle steps in Xxxxx Center are prohibited. F. Contact information must be available to patrons to arrange for disability accommodations. This information should be provided in all marketing materials as well as all ticket sales locations. G. Renter must reserve twelve (12) tickets for Xxxxx Center’s use, and if the event is reserved seating, the following seats are required: R2, 4, 6, 8, 10, 12: N29, 31, 33, 35: and O33, 35. These twelve (12) tickets must be se...
Sample 1
Selling Tickets. Generally, you may not sell tickets at either private or public showings, as doing so is almost certainly a violation of the copyright of the DVD that you are using. If you have obtained written copyright privileges to the content, or if the content has been created by you, this ticket selling prohibition is waived. (Movie houses are closely scrutinized for copyright violations, so this is an important issue to us.)
Sample 1
Selling Tickets. 7.1. Once your Event is registered by us in accordance with this Agreement, we may sell Tickets to the Event via the FringeTIX website. 7.2. After purchasing a Ticket, buyers will be provided by us a URL to view the Event on YouTube. 7.3. You must not sell or authorise the sale of Tickets via any other means, and you agree that we have the right to conduct the exclusive sale, distribution and issue of all Tickets for your Event(s) through Adelaide Fringe’s ticketing system ‘FringeTIX’: 7.3.1. for ticket categories and prices as inputted by either Adelaide Fringe, or you into the AVR site; 7.3.2. for selected customers associated with Adelaide FringeVIEW sponsors and Fringe Members as part of an exclusive pre-sale, from Midday 29th April to Midday 1st May 2020. 7.3.3. for all other customers from Midday 1st May 2020 until Midnight 31st May 2020; and 7.3.4. providing all requirements are met, Adelaide Fringe may release tickets earlier than dates referenced above for early on- sale, upon notice in writing to you. 7.4. Adelaide Fringe have exclusive Ticketing sales rights to all 2020 Adelaide FringeVIEW events and this is a condition of your registration and participation, unless you receive prior approval in writing by the Adelaide Fringe Director & Chief Executive. 7.5. Adelaide Fringe through FringeTIX, will sell tickets until 31st May 2020 to your Events, unless cancelled earlier or if this agreement is terminated. 7.6. Adelaide Fringe will implement e-Ticketing as the delivery method for customers at FringeTIX point of sale online. Customers will be provided with an email Ticket confirmation and their URL link to your Event. 7.7. Only you will be able to download a copy of the FringeTIX sales report detailing Tickets sold, associated customer names and details if the customer has opted into providing you with this data. 7.8. You are responsible for communicating all necessary details for Ticket holders prior to purchase, within your Event description on the web listing. Adelaide Fringe will not email Ticket buyers on your behalf, or provide you with a list of emails of Ticket buyers as this is a breach of Privacy Laws.
Sample 1
AutoNDA by SimpleDocs

Related to Selling Tickets

  • Distributor The Trust hereby appoints the Distributor as general distributor of shares of beneficial interest (“Series shares”) of the Trust’s WCM Funds series (the “Series”) during the term of this Agreement. The Trust reserves the right, however, to refuse at any time or times to sell any Series shares hereunder for any reason deemed adequate by the Board of Trustees of the Trust.

  • Tickets Each Ticket represents a limited, revocable license to enter the Venue to attend the specific Event listed on the applicable Ticket. No person, except for attendees under the age of three, may enter the Venue without a Ticket, and re-entry is prohibited. Failure to comply with this Agreement shall result in forfeiture of this license and all rights arising hereunder without refund or credit and shall entitle KSE to pursue all legal remedies available.

  • Wholesaler is not allowed to use MMCAP Infuse’s contract pricing to calculate its Generic Drug Program Pricing.

  • Distributors In addition to direct sales to Clients, Supplier grants Accenture: (i) the right to resell Products and Services to a third-party

  • End Users Customer will control access to and use of the Products by End Users and is responsible for any use of the Products that does not comply with this Agreement.

  • COMPLIMENTARY TICKETS Hirer can allocate up to 2% in number of the tickets for each performance or day of the Event as complimentary tickets.

  • Sales On the settlement date for a sale, Bank will credit the Cash Account with the proceeds of the sale and transfer the relevant Financial Assets to an account at the Bank pending settlement of the trade where not already delivered.

  • Resellers Does the vendor have resellers that it will name under this contract? Resellers are defined as other companies that sell your products under an agreement with you, the awarded vendor of TIPS. No Does the vendor agrees to honor the proposed pricing discount percentage off regular catalog (as defined in the RFP document), website, store or shelf pricing for the term of the award? YES

  • Product Sales Subject to Sections 10.3(c) and 10.3(d), Licensee agrees that it will not sell, offer for sale, or assist third parties (including Affiliates) in selling Product except for the sale and offer for sale of (A) TAF Product, TAF Combination Product, TDF Product and TDF Combination Product for use in the Field and in the countries of the TDF-TAF Territory, (B) COBI Product and COBI Combination Product for use in the Field and in the countries of the COBI Territory, and (C) EVG Product, EVG Combination Product and Quad Product for use in the Field and in the countries of the EVG-Quad Territory.‌ (i) Licensee agrees that during the period in which the Patents are valid and enforceable (on a Product-by-Product basis) it will prohibit its Distributors from selling Product (A) to any other wholesaler or distributor, (B) outside the Territory for which Licensee is licensed for sale of such Product pursuant to Section 2.2, or (C) for any purpose outside the Field. (ii) Licensee agrees that it will not administer the TAF Quad to humans, or sell the TAF Quad until Gilead has obtained marketing approval for the TAF Quad from the FDA. Licensee agrees that it will not administer EVG to humans, or sell Products containing EVG until Gilead has obtained marketing approval for an EVG Product from the FDA. Licensee agrees that it will not administer COBI to humans, or sell Products containing COBI until Gilead has obtained marketing approval for a COBI Product from the FDA. Licensee agrees that it will not administer TAF to humans, or sell Products containing TAF until Gilead has obtained marketing approval for a TAF Product from the FDA. If Gilead obtains marketing approval from the FDA for any Quad Product or a Combination Product containing TAF, COBI or EVG (“Approved Combination Product”) prior to obtaining marketing approval for a TAF Product, EVG Product or COBI Product from the FDA, then Licensee will be allowed to administer such Quad Product or such Approved Combination Product to humans, and sell such Quad Product or such Approved Combination Product from and after the date of such marketing approval from the FDA, but will not (A) administer to humans or sell Combination Products containing EVG other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for an EVG Product, or (B) administer to humans or sell Combination Products containing COBI other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for a COBI Product or (C) administer to humans or sell Combination Products containing TAF other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for a TAF Product.

  • SELLING STOCKHOLDERS

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!